Abstract
Colorectal cancer (CRC) is a malignant epithelial neoplasm (adenocarcinoma) developing in the glandular tissue of the colon or rectum. The great majority of CRCs develop from adenomatous colorectal polyps in a process called the adenoma-carcinoma sequence (Muto et al., Cancer 36(6):2251–2270, 1975). Colorectal polyps are a histopathologic group of benign lesions that include hyperplastic and adenomatous polyps that project above the surrounding mucosa as well as the less common, non-polypoid polyps. The adenomatous polyps (adenomas) are benign, neoplastic precursors that arise in the colorectal glandular epithelium. In the United States (USA), colorectal adenoma (CRA) prevalence is approximately 25 % by age 50 and rises to around 50 % by age 70. The histological hallmarks of a CRA are altered glandular architecture and dysplasia of the epithelium. A benign CRA progresses to invasive CRC when the dysplastic cells gain the capacity to invade through the muscularis mucosa. The development of invasive cancer from the earliest CRA may take from years to decades. While most CRCs develop from CRAs, the slow rate of progress results in less than 10 % ever progressing to CRC. In this chapter, we review the molecular characteristics of the disease and provide an update on the epidemiology including reviewing evidence for established and suspected risk factors for CRC. Given the dramatic impact that screening and early detection have had on reducing the incidence and mortality suspected of CRC and death from CRC, we have included a detailed review of the different screening recommendations and their efficacy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abraham C, Cho JH (2009) Inflammatory bowel disease. N Engl J Med 361(21):2066–2078
Ahlquist DA, Wieand HS et al (1993) Accuracy of fecal occult blood screening for colorectal neoplasia. JAMA 269:1262–1267
Ahlquist DA, Skoletsky JE et al (2000) Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 119:1219–1227
Ahlquist DA, Sargent DJ et al (2008) Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 149(7):441–450, W81
Ahlquist DA, Zou H et al (2012) Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology 142(2):248–256; quiz e25–e26
Alberts DS, Martínez ME et al (2000) Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. N Engl J Med 342:1156–1162
Alberts DS, Martinez ME et al (2005) Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst 97(11):846–853
Allison JE (2010) FIT: a valuable but underutilized screening test for colorectal cancer-it’s time for a change. Am J Gastroenterol 105(9):2026–2028
Allison JE, Sakoda LC et al (2007) Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 99(19):1462–1470
Allison JE, Fraser CG et al (2012) Comparing fecal immunochemical tests: improved standardization is needed. Gastroenterology 142(3):422–424
Anonymous (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. World Cancer Research Fund, Washington, DC
Arber N, Eagle CJ et al (2006) Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 355(9):885–895
Atkin WS, Edwards R et al (2010) Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375(9726):1624–1633
Aune D, Chan DS et al (2011) Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose–response meta-analysis of prospective studies. BMJ 343:d6617
Austin GL, Fennimore B et al (2012) Can colonoscopy remain cost-effective for colorectal cancer screening? The impact of practice patterns and the will Rogers phenomenon on costs. Am J Gastroenterol 108(3):296–301
Bakhoum SF, Compton DA (2012) Chromosomal instability and cancer: a complex relationship with therapeutic potential. J Clin Invest 122(4):1138–1143
Baron JA, Beach M et al (1999) Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 340(2):101–107
Baron JA, Cole BF et al (2003) A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348(10):891–899
Baron JA, Sandler RS et al (2006) A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology 131(6):1674–1682
Baxter NN, Goldwasser MA et al (2009) Association of colonoscopy and death from colorectal cancer. Ann Intern Med 150(1):1–8
Ben Q, An W et al (2012) Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology 142(4):762–772
Benamouzig R, Deyra J et al (2003) Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial1. Gastroenterology 125(2):328–336
Bertagnolli MM, Eagle CJ et al (2006) Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 355(9):873–884
Beuers U (2006) Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol 3(6):318–328
Botteri E, Iodice S et al (2008) Smoking and colorectal cancer: a meta-analysis. JAMA 300(23):2765–2778
Bowles CJ, Leicester R et al (2004) A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? Gut 53(2):277–283
Brawley O, Byers T et al (2011) New American Cancer Society process for creating trustworthy cancer screening guidelines. JAMA 306(22):2495–2499
Brenner DJ, Georgsson MA (2005) Mass screening with CT colonography: should the radiation exposure be of concern? Gastroenterology 129(1):328–337
Brenner DJ, Doll R et al (2003) Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci U S A 100(24):13761–13766
Brenner H, Hoffmeister M et al (2009) Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: estimates based on 1,875,708 screening colonoscopies. Eur J Cancer 45(11):2027–2033
Brenner H, Hoffmeister M et al (2010) Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst 102:89–95
Bresalier RS, Sandler RS et al (2005) Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352(11):1092–1102
Burn J, Gerdes AM et al (2011) Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 378(9809):2081–2087
Butterworth AS, Higgins JP et al (2006) Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 42(2):216–227
Center MM, Jemal A et al (2009a) Worldwide variations in colorectal cancer. CA Cancer J Clin 59(6):366–378
Center MM, Jemal A et al (2009b) International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 18(6):1688–1694
Chan AT, Giovannucci EL (2010) Primary prevention of colorectal cancer. Gastroenterology 138(6):2029–2043.e10
Chan AT, Giovannucci EL et al (2004) A prospective study of aspirin use and the risk for colorectal adenoma. Ann Intern Med 140(3):157–166
Chan DS, Lau R et al (2011) Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One 6(6):e20456
Chan AT, Arber N et al (2012) Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res (Phila) 5(2):164–178
Cho E, Smith-Warner SA et al (2004a) Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med 140(8):603–613
Cho E, Smith-Warner SA et al (2004b) Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst 96(13):1015–1022
Clark L, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL, Taylor JR (1996) Effects of selenium supplementation for cancer prevention in patient with carcinomas of the skin. JAMA 276:1957–1963
Colditz GA, Wei EK (2012) Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality. Annu Rev Public Health 33:137–156
Colditz GA, Wolin KY et al (2012) Applying what we know to accelerate cancer prevention. Sci Transl Med 4(127):127rv4
Cole BF, Baron JA et al (2007) Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 297(21):2351–2359
Cole BF, Logan RF et al (2009) Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst 101(4):256–266
Cooper GS, Kou TD et al (2013) Complications following colonoscopy with anesthesia assistance: a population-based analysis. JAMA Intern Med 173:551–556
Corley DA, Jensen CD et al (2011) Can we improve adenoma detection rates? A systematic review of intervention studies. Gastrointest Endosc 74(3):656–665
Cotton PB, Durkalski VL et al (2004) Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA 291(14):1713–1719
Cross AJ, Ferrucci LM et al (2010) A large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association. Cancer Res 70(6):2406–2414
Cruz-Correa M, Hylind LM et al (2002) Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Gastroenterology 122(3):641–645
Cryer B (2002) Gastrointestinal safety of low-dose aspirin. Am J Manag Care 8(22 Suppl):S701–S708
Cryer B, Kimmey MB (1998) Gastrointestinal side effects of nonsteroidal anti-inflammatory drugs. Am J Med 105(1B):20S–30S
Danese S, Fiocchi C (2011) Ulcerative colitis. N Engl J Med 365(18):1713–1725
de Wijkerslooth TR, Stoop EM et al (2012) Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol 107(10):1570–1578
Degirolamo C, Modica S et al (2011) Bile acids and colon cancer: solving the puzzle with nuclear receptors. Trends Mol Med 17(10):564–572
Demierre MF, Higgins PD et al (2005) Statins and cancer prevention. Nat Rev Cancer 5(12):930–942
Derry S, Loke YK (2000) Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ 321(7270):1183–1187
Doubeni CA, Weinmann S et al (2013) Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med 158(5 Pt 1):312–320
Dube C, Rostom A et al (2007) The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 146(5):365–375
Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, Slate EH, Fischbach LA, Marshall JR, Clark LC (2002) Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 11:630–639
Edwards BK, Ward E et al (2010) Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116(3):544–573
Elmunzer BJ, Hayward RA et al (2012) Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 9(12):e1001352
Emami Riedmaier A, Fisel P et al (2013) Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects. Trends Pharmacol Sci 34(2):126–135
Farraye FA, Odze RD et al (2010) AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 138(2):746–774, 774 e1–e4; quiz e12–e13
Feagins LA, Souza RF et al (2009) Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. Nat Rev Gastroenterol Hepatol 6(5):297–305
Fearon ER (2011) Molecular genetics of colorectal cancer. Annu Rev Pathol 6:479–507
Frazier AL, Colditz GA et al (2000) Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 284:1954–1961
Friedman AC, Downing D et al (2010) Feasibility of remote CT colonography at two rural Native American medical centers. AJR Am J Roentgenol 195(5):1110–1117
Fuchs CS, Willett WC et al (2002) The influence of folate and multivitamin use on the familial risk of colon cancer in women. Cancer Epidemiol Biomarkers Prev 11:227–234
Gandini S, Boniol M et al (2011) Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 128(6):1414–1424
Gatto NM, Frucht H et al (2003) Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst 95(3):230–236
Giovannucci E (2004) Alcohol, one-carbon metabolism, and colorectal cancer: recent insights from molecular studies. J Nutr 134(9):2475S–2481S
Giovannucci EL, Stampfer MJ et al (1998) Multivitamin use, folate, and colon cancer in women in nurses’ health study. Ann Intern Med 129:517–524
Gong J, Hutter C et al (2012) A pooled analysis of smoking and colorectal cancer: timing of exposure and interactions with environmental factors. Cancer Epidemiol Biomarkers Prev 21(11):1974–1985
Grady WM (2003) Genetic testing for high-risk colon cancer patients. Gastroenterology 124(6):1574–1594
Graser A, Melzer A et al (2013) Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults. Gastroenterology 144:743–750.e2
Grau MV, Baron JA et al (2003) Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 95(23):1765–1771
Green BB, Wang CY et al (2013) An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med 158(5 Pt 1):301–311
Haenszel W, Kurihara M (1968) Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40(1):43–68
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674
Hassan C, Pickhardt PJ (2013) Management of subcentimetric polyps detected by CT colonography. Nat Rev Gastroenterol Hepatol 10(2):119–124
Hill MJ (1975) Metabolic epidemiology of dietary factors in large bowel cancer. Cancer Res 35(11 Pt. 2):3398–3402
Imperiale TF, Ransohoff DF (2012) Risk for colorectal cancer in persons with a family history of adenomatous polyps: a systematic review. Ann Intern Med 156(10):703–709
Jacobs ET, Ahnen DJ et al (2009) Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study. Am J Epidemiol 169(6):657–666
Jasperson KW, Tuohy TM et al (2010) Hereditary and familial colon cancer. Gastroenterology 138(6):2044–2058
Jass JR (2007) Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50(1):113–130
Johns LE, Houlston RS (2001) A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 96(10):2992–3003
Johnson CD, Chen MH et al (2008) Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 359(12):1207–1217
Kaminski MF, Regula J et al (2010) Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 362(19):1795–1803
Kershenbaum A, Flugelman A et al (2013) Excellent performance of Hemoccult Sensa in organised colorectal cancer screening. Eur J Cancer 49(4):923–930
Kim YI (2006) Folate: a magic bullet or a double edged sword for colorectal cancer prevention? Gut 55(10):1387–1389
Knudsen AB, Lansdorp-Vogelaar I et al (2010) Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population. J Natl Cancer Inst 102(16):1238–1252
Korman LY (2012) Standardization of endoscopy reporting: déjà Vu all over again? Clin Gastroenterol Hepatol 10(9):956–959
Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, Gladyshev VN (2003) Characterization of mammalian selenoproteomes. Science 300:1439–1443
Kushi LH, Doyle C et al (2012) American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 62(1):30–67
Lance P (2008) Chemoprevention for colorectal cancer: some progress but a long way to go. Gastroenterology 134(1):341–343
Lawson KR, Ignatenko NA et al (2000) Influence of K-ras activation on the survival responses of Caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine. Cancer Epidemiol Biomarkers Prev 9(11):1155–1162
Lee IM, Shiroma EJ et al (2012) Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 380(9838):219–229
Lengauer C, Kinzler KW et al (1998) Genetic instabilities in human cancers. Nature 396:643–649
Levin TR (2011) Optimizing colorectal cancer screening by getting FIT right. Gastroenterology 141(5):1551–1555
Levin B, Lieberman DA et al (2008) Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: a Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 58:130–160
Lichtenstein P, Holm NV et al (2000) Environmental and heritable factors in the causation of cancer. N Engl J Med 343:78–85
Lieberman D (2013) The cheesecake factory: lessons for expanding the menu for colorectal cancer screening. Gastroenterology 144:684–686
Lieberman DA, Rex DK et al (2012) Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 143(3):844–857
Lochhead P, Chan AT (2013) Statins and colorectal cancer. Clin Gastroenterol Hepatol 11(2):109–118
Logan RF, Grainge MJ et al (2008) Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 134(1):29–38
Logan RF, Patnick J et al (2012) Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut 61(10):1439–1446
Mandel JS, Church TR et al (1999) Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91:434–437
Mandel JS, Church TR et al (2000) The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343(22):1603–1607
Markowitz SD, Bertagnolli MM (2009) Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med 361(25):2449–2460
Martinez ME, Willett WC (1998) Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 7(2):163–168
Martinez ME, Baron JA et al (2009) A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 136(3):832–841
Meyskens FL Jr, Gerner EW et al (1998) Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention. J Natl Cancer Inst 90(16):1212–1218
Meyskens FL Jr, McLaren CE, Pelot D, Fujikawa-Brooks S, Carpenter PM, Hawk E, Kelloff G, Lawson MJ, Kidao J, McCracken J, Albers CG, Ahnen DJ, Turgeon DK, Goldschmid S, Lance P, Hagedom CH, Gillen DL, Gerner EW (2008) Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res 1:32–38
Mitka M (2008) Colorectal cancer screening rates still fall far short of recommended levels. JAMA 299(6):622
Mowat C, Cole A et al (2011) Guidelines for the management of inflammatory bowel disease in adults. Gut 60(5):571–607
Munkholm P (2003) Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 18(Suppl 2):1–5
Muto T, Bussey HJ et al (1975) The evolution of cancer of the colon and rectum. Cancer 36(6):2251–2270
Nelson EB, McQuaid KR et al (2002) Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc 55:307–314
Newcomb PA, Norfleet RG et al (1992) Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84(20):1572–1575
Ng SC, Lau JY et al (2013) Increased risk of advanced neoplasms among asymptomatic siblings of patients with colorectal cancer. Gastroenterology 144(3):544–550
Nguyen GC, Gulamhusein A et al (2012) 5-aminosalicylic Acid is not protective against colorectal cancer in inflammatory bowel disease: a meta-analysis of non-referral populations. Am J Gastroenterol 107(9):1298–1304
Niv Y, Lev-El M et al (2002) Protective effect of faecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers. Gut 50(1):33–37
Noffsinger AE (2009) Serrated polyps and colorectal cancer: new pathway to malignancy. Annu Rev Pathol 4:343–364
Osborn NK, Ahlquist DA (2005) Stool screening for colorectal cancer: molecular approaches. Gastroenterology 128(1):192–206
Pardi DS, Loftus EV Jr et al (2003) Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 124:889–893
Park DI, Ryu S et al (2010) Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol 105(9):2017–2025
Pearson JR, Gill CI et al (2009) Diet, fecal water, and colon cancer – development of a biomarker. Nutr Rev 67(9):509–526
Peto J (2001) Cancer epidemiology in the last century and the next decade. Nature 411(6835):390–395
Pickhardt PJ (2012) Strong evidence in support of CT colonography screening. Lancet Oncol 13(1):6–7
Pickhardt PJ, Choi JR et al (2003) Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 349(23):2191–2200
Pohl H, Robertson DJ (2010) Colorectal cancers detected after colonoscopy frequently result from missed lesions. Clin Gastroenterol Hepatol 8(10):858–864
Popkin BM (1994) The nutrition transition in low-income countries: an emerging crisis. Nutr Rev 52(9):285–298
Potter JD (1999) Colorectal cancer: molecules and populations. J Natl Cancer Inst 91(11):916–932
Qaseem A, Denberg TD et al (2012) Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med 156(5):378–386
Raja Ali RA, Dooley C et al (2011) Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease. Clin Gastroenterol Hepatol 9(7):584–589.e2
Reddy BS, Hanson D et al (1980) Effect of high-fat, high-beef diet and of mode of cooking of beef in the diet on fecal bacterial enzymes and fecal bile acids and neutral sterols. J Nutr 110(9):1880–1887
Regge D, Laudi C et al (2009) Diagnostic accuracy of computed tomographic colonography for the detection of advanced neoplasia in individuals at increased risk of colorectal cancer. JAMA 301(23):2453–2461
Renehan AG, Flood A et al (2012) Body mass index at different adult ages, weight change, and colorectal cancer risk in the National Institutes of Health-AARP Cohort. Am J Epidemiol 176:1130–1140
Rex DK (2011) Can we fix colonoscopy?…Yes! Gastroenterology 140(1):19–21
Rex DK, Cutler CS et al (1997) Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 112:24–28
Rex DK, Petrini JL et al (2006) Quality indicators for colonoscopy. Gastrointest Endosc 63(4 Suppl):S16–S28
Rex DK, Ahnen DJ et al (2012) Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 107:1315–1329
Rothwell PM, Wilson M et al (2010) Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376(9754):1741–1750
Rutter M, Saunders B et al (2004) Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126(2):451–459
Sandler RS, Halabi S et al (2003) A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 348:883–890
Sanduleanu S, Masclee AM et al (2012) Interval cancers after colonoscopy-insights and recommendations. Nat Rev Gastroenterol Hepatol 9(9):550–554
Schatzkin A, Lanza E et al (2000) Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med 342(16):1149–1155
Schoen RE, Pinsky PF et al (2012) Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 366(25):2345–2357
Selby JV, Friedman GD et al (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326(10):653–657
Siegel RL, Ward EM et al (2012) Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992–2008. Cancer Epidemiol Biomarkers Prev 21(3):411–416
Siegel R, Naishadham D et al (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1):11–30
Singh H, Nugent Z et al (2010) The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology 139(4):1128–1137
Smith RA, Cokkinides V et al (2011) Cancer screening in the United States, 2011: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 61(1):8–30
Smith RA, Brooks D et al (2013) Cancer screening in the United States, 2013: a review of current American Cancer Society Guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin 63(2):87–105
Smith-Bindman R (2010) Is computed tomography safe? N Engl J Med 363(1):1–4
Soetikno RM, Kaltenbach T et al (2008) Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA 299(9):1027–1035
Solomon SD, McMurray JJ et al (2005) Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 352(11):1071–1080
Solomon SD, Wittes J et al (2008) Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis. Circulation 117(16):2104–2113
Spirio LN, Samowitz W et al (1998) Alleles of APC modulate the frequency and classes of mutations that lead to colon polyps. Nat Genet 20:385–388
Sporn MB, Dunlop NM et al (1976) Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 35(6):1332–1338
St John DJ, Young GP et al (1993) Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 104(6):1661–1668
Steinbach G, Lynch PM et al (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946–1952
Stock C, Ihle P et al (2013) Adverse events requiring hospitalization within 30 days after outpatient screening and nonscreening colonoscopies. Gastrointest Endosc 77(3):419–429
Stoop EM, de Haan MC et al (2012) Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol 13(1):55–64
Taubes G (2012) Cancer research. Unraveling the obesity-cancer connection. Science 335(6064):28, 30–32
Thompson PA, Wertheim BC et al (2009) Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients. Cancer Prev Res (Phila Pa) 2(12):1023–1030
Thompson P, Roe DJ, Fales L, Buckmeier J, Wang F, Hamilton SR, Bhattacharyya A, Green S, Hsu CH, Chow HH, Ahnen DJ, Boland CR, Heigh RI, Fay DE, Martinez ME, Jacobs E, Ashbeck EL, Alberts DS, Lance P (2012) Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention. Cancer Prev Res (Phila) 5:1381–1393
Thun MJ, Jacobs EJ et al (2012) The role of aspirin in cancer prevention. Nat Rev Clin Oncol 9:259–267
Tung BY, Emond MJ et al (2001) Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med 134:89–95
USPSTF (2008) Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 149(9):627–637
USPSTF (2012) Grade definitions. From http://www.uspreventiveservicestaskforce.org/uspstf/grades.htm
van Rijn JC, Reitsma JB et al (2006) Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 101(2):343–350
Venturi M, Hambly RJ et al (1997) Genotoxic activity in human faecal water and the role of bile acids: a study using the alkaline comet assay. Carcinogenesis 18(12):2353–2359
Vilar E, Gruber SB (2010) Microsatellite instability in colorectal cancer-the stable evidence. Nat Rev Clin Oncol 7(3):153–162
von Karsa L, Patnick J et al (2012) European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition – Executive summary. Endoscopy 44(Suppl 3):SE1–SE8
Wang J, Joshi AD et al (2012) Carcinogen metabolism genes, red meat and poultry intake, and colorectal cancer risk. Int J Cancer 130(8):1898–1907
Ward E, Jemal A et al (2004) Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54(2):78–93
Wei MY, Garland CF et al (2008) Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiol Biomarkers Prev 17(11):2958–2969
Whynes DK, Frew EJ et al (2003) Colorectal cancer, screening and survival: the influence of socio-economic deprivation. Public Health 117(6):389–395
Winawer SJ, Zauber AG et al (1993a) Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 329:1977–1981
Winawer SJ, Zauber AG et al (1993b) Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 328(13):901–906
Winawer SJ, Fletcher RH et al (2003) Colorectal cancer screening and surveillance: clinical guidelines and rationale−update based on new evidence. Gastroenterology 124:544–560
Xie J, Itzkowitz SH (2008) Cancer in inflammatory bowel disease. World J Gastroenterol 14(3):378–389
Yin L, Grandi N et al (2009) Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther 30(2):113–125
Yuhara H, Steinmaus C et al (2011) Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol 106(11):1911–1921
Zauber AG, Winawer SJ et al (2012) Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366(8):687–696
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lance, P., Thompson, P. (2014). Prevention of Colorectal Cancer. In: Alberts, D., Hess, L. (eds) Fundamentals of Cancer Prevention. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-38983-2_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-38983-2_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-38982-5
Online ISBN: 978-3-642-38983-2
eBook Packages: MedicineMedicine (R0)